3 Penny Stocks to Watch As 2021 Comes to an End
With the end of 2021 only a few weeks away, investors continue to search for the best penny stocks to buy. Now, if you’ve traded penny stocks in the last few months, you are likely used to the sizable amount of volatility in the stock market.
Although volatility is normal with penny stocks, the level at which we’ve seen market fluctuations in the past couple of months is unparalleled. This is the result of the sheer number of factors that are impacting the stock market right now. At the top of the list we have the pandemic and the addition of the Omicron variant. While initial studies are showing that this variant could be less detrimental than previously imagined, it has still shaken up markets significantly.
[Read More] 3 Hot Penny Stocks To Buy In December According To Insiders
Next on the list we have inflation and a general air of uncertainty surrounding the future. On one hand, inflation has caused the price of certain goods to soar, which is a positive for some stocks. However, it has also caused the devaluing of others and worries about what the future of the U.S. economy could look like. So, while all of these factors may incite fear initially, volatility is something that can benefit investors if used correctly. Considering all of this, let’s take a look at three penny stocks to watch right now.
3 Penny Stocks For Your Watchlist Right Now
- Gaotu Techedu Inc. (NYSE: GOTU)
- 1847 Goedeker Inc. (NYSE: GOED)
- Jaguar Health Inc. (NASDAQ: JAGX)
Gaotu Techedu Inc. (NYSE: GOTU)
Gaotu Techedu Inc. is an education penny stock managed to climb by more than 2% on December 9th and over 8% in the past five days. In China, the company offers after-school tutoring to kids in grades K-12. It provides a wide range of disciplines such as math, English, Chinese, chemistry, and others. Additionally, the company offers business consultancy courses to principals and other administrators at private schools.
On November 15th, the corporation published updated business information. Gaotu has announced that it would cease providing tutoring services to students in grades K-9 by the end of 2021. This is because of new laws enacted by the Chinese government. Other parts of the company’s business will continue to operate as normal, however, its tutoring business is highly fractured. Gaotu Techedu anticipates that the discontinuation of these services will have a significant negative impact on the Company’s revenues for the fiscal year ending December 31, 2021, and following periods.
Now, the business’s plan is to evaluate potential strategic options that may effectively harness the resources and know-how gathered via its previous K-9 Academic AST Services. Gaotu will investigate the possibility of offering courses and services for professional education, as well as investigating opportunities in digital products and vocational education. In the last 5 days, GOTU stock has experienced a lot of activity. With all of this in mind, will GOTU be on your penny stock watchlist?
1847 Goedeker Inc. (NYSE: GOED)
1847 Goedeker Inc. is a penny stock that we have discussed numerous times in the past few months. If you’re unfamiliar, this company runs an e-commerce platform that sells appliances, furniture, fitness equipment, televisions, and other items. Home improvement has been a huge market in the last year amid the pandemic and the rise in the number of individuals buying homes. This is a major positive for Goedeker and has helped to bring in a significant amount of attention to the company.
[Read More] 4 Penny Stocks That Are Trending on Reddit Right Now and Why
On November 15th, 1847 Goedeker announced its third-quarter results for 2021. During this period, its net sales increased to $141.9 million compared to proforma net sales of $102.2 million the previous year. Its gross profit increased to $31.4 million compared to $21 million year over year as well. In total, its proforma net income for this period was $3.9 million compared to a loss of $0.7 million last year.
“Our increased scale positioned us to obtain inventory, meet increased customer demand and mitigate the full impact of global supply chain constraints. We feel well-positioned from an inventory perspective heading into next quarter, and we will continue to execute against our outlined priorities and aggressively pursue greater market share.”
The CEO and Director of Goedeker, Albert Fouerti
On December 9th, GOED stock managed to climb by over 4% at the market close. Considering this, will GOED stock be on your watchlist moving into 2022?
Jaguar Health Inc. (NASDAQ: JAGX)
Jaguar Health Inc. is a biotech company based in the United States that develops prescription medications. Jaguar’s products are novel, plant-based, non-opioid, and sustainably derived prescription medicines. The products are designed for people and animals suffering from chronic or debilitating gastrointestinal issues. Napo Pharmaceuticals Inc., a subsidiary of Jaguar, develops and commercializes gastrointestinal pharmaceuticals as well, which is a complementary business.
On November 17th, Jaguar reported its financial results for 2021. The company’s prescription volume for Mytesi increased 7.6% quarter over quarter. Its Mytesi net and gross sales were $0.6 million and $3.2 million. Mytesi is an antidiarrheal medication used to treat noninfectious diarrhea in adult HIV/AIDS patients on antiretroviral therapy (ART). It’s worth noting that Mytesi is the only oral plant-based prescription drug approved under FDA Botanical Guidance for the symptomatic treatment of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Financially, Jaguar’s R&D expenses for the third quarter of 2021 were $3.3 million compared to $1.5 million the year before. Its sales and marketing expenses were $2.3 million compared to $1.5 million last year. Moving forward, the company will be hosting a scientific discussion about cancer therapy-related diarrhea in breast cancer at the San Antonio Breast Cancer Symposium aka SABCS 2021. It will also discuss its ongoing OnTarget pivotal Phase 3 trial at the event as well. OnTarget is the company’s pivotal Phase 3 clinical trial of crofelemer in adult cancer patients undergoing targeted therapy for diarrhea prevention. Before this discussion takes place, will JAGX make your list of penny stocks to watch?
Which Penny Stocks Are You Watching Right Now?
With so many penny stocks to choose from, it can seem difficult to pick just a handful for your watchlist. But, because there is such a large number of penny stocks out there, the options and opportunities to make money with small-caps is more than palpable.
[Read More] Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch
While it may be difficult at first, having a trading strategy will be your best bet to making money with penny stocks. Considering all of this, which penny stocks are you watching right now?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!
